• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Orix Corporation ADR

Orix Corporation ADR

DB Base Metals Short ETN BOS

Last Price$22.26Day Change (%)-0.40%
Open Price$22.26Day Change ($)-0.09
Day Range22.26–22.2652-Week Range17.83–39.15

As of Wed 1/18/2017 11:48:00 AM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. RED Capital Group Celebrates 50 Unique Loan Closings Totaling over $340M with Long-standing Partner Redwood Living

    RED Capital Group Celebrates 50 Unique Loan Closings Totaling over $340M with Long-standing Partner Redwood Living

  2. New York & Company, Inc. Comments on Holiday Performance and Fourth Quarter Outlook

    New York & Company, Inc. Comments on Holiday Performance and Fourth Quarter Outlook

  3. Apollo Education Group, Inc. Reports First Quarter Fiscal Year 2017 Results

    Apollo Education Group, Inc. Reports First Quarter Fiscal Year 2017 Results

  4. Envision Healthcare Expands Physician Services in Arizona by Acquiring Tucson-Area Anesthesia Group

    Envision Healthcare Expands Physician Services in Arizona by Acquiring Tucson-Area Anesthesia Group

  5. Carrie Fisher dies at age 60: Remembering her life in photos

    Carrie Fisher dies at age 60: Remembering her life in photos

  6. Advisor's Guide to Qualified Charitable Distributions

    Who can do these beneficial transfers, with how much money, to what kinds of charities--and how to execute (and report) the QCD.

  7. Fidelity to Create New Sector Fund Board, Advisor

    Rabobank finally settles on a buyer for most of Robeco, Fidelity to close Fidelity Small Cap Value, Matthews Asia to launch 2 new funds, and Victory Capital gains independence.

  8. Moats and Growth Drivers Look Solid for Post-Split Baxter

    Focus remains on hemophilia competition, but Baxter's comprehensive product portfolios are unmatched.

  9. Novo's Scale Advantages and Drug Lineup Broaden Its Wide Moat

    Regulatory issues that we believe have little impact on Novo Nordisk's long-run prospects have finally helped shares of the leading insulin maker go on sale.

  10. Our Outlook for the Municipal Markets

    Relevant questions (and answers) for investors as they continue their research into bankruptcy and pension issues.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.